← Leaderboards
Mark C Walters
Children'S Hospital &Res Ctr At Oakland
$10,183,063
Attributed
$16,814,955
Total exposure
6
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2006–25$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,814,955 · 6
By mechanism
U01$9,409,918 · 2
TL1$3,908,456 · 1
OT2$2,201,994 · 1
R34$734,295 · 1
U10$560,292 · 1
Top collaborators
- Lakshmanan Krishnamurti11 shared
- Philip A Beachy3 shared
- Chi-Yuan Hsu3 shared
Others in their field
Top investigators on “Sickle Cell Anemia”
- Russell E Ware · Duke University$48,435,687
- Michael Rutledge Debaun · Vanderbilt University Medical Center$38,268,866
- Martin H. Steinberg · Boston Medical Center$25,628,557
- Michael L. Terrin · Clinical Trials And Surveys Corporation$23,855,067
- Barbara L Kroner · Research Triangle Institute$21,141,016
- Garret A Fitzgerald · University Of Pennsylvania$20,602,198
Research focus
Sickle Cell AnemiaPreventResearch PersonnelFundingClinical TrialsSafetySicklingMedicalCaringAdultEngraftmentDisease-Free SurvivalQuality Of LifeSiblingsChildChildhoodSupportive CareComprehensive Health CareEnrollmentBone Marrow TransplantationOrganHydroxyureaInnovationFuture
Grant awards (25)
NRSA Training Core$1,272,150
TL1 · FY2025 · DK
NRSA Training Core$1,368,023
TL1 · FY2024 · DK
NRSA Training Core$1,268,283
TL1 · FY2023 · DK
Curing Sickle Cell Disease with CRISPR-Cas9 genome editing$25,000
OT2 · FY2021 · HL · contact PI
Curing Sickle Cell Disease with CRISPR-Cas9 genome editing$476,994
OT2 · FY2020 · HL · contact PI
Curing Sickle Cell Disease with CRISPR-Cas9 genome editing$1,700,000
OT2 · FY2019 · HL · contact PI
Hematopoietic Stem Cell Transplantation for Young Adults with Sickle Cell Disease - Clinical Coordinating Center$885,624
U01 · FY2019 · HL
Hematopoietic Stem Cell Transplantation for Young Adults with Sickle Cell Disease - Clinical Coordinating Center$467,070
U01 · FY2019 · HL
Hematopoietic Stem Cell Transplantation for Young Adults with Sickle Cell Disease - Clinical Coordinating Center$1,465,478
U01 · FY2018 · HL
Hematopoietic Stem Cell Transplantation for Young Adults with Sickle Cell Disease - Clinical Coordinating Center$1,483,446
U01 · FY2017 · HL
Hematopoietic Stem Cell Transplantation for Young Adults with Sickle Cell Disease - Clinical Coordinating Center$92,934
U01 · FY2017 · HL
Hematopoietic Stem Cell Transplantation for Young Adults with Sickle Cell Disease - Clinical Coordinating Center$1,454,461
U01 · FY2016 · HL
Hematopoietic Stem Cell Transplantation for Young Adults with Sickle Cell Disease - Clinical Coordinating Center$1,469,202
U01 · FY2015 · HL
Hematopoietic Cell Therapy for Young Adults with Severe Sickle Cell Disease$154,826
R34 · FY2013 · HL
Hematopoietic Cell Therapy for Young Adults with Severe Sickle Cell Disease$76,729
R34 · FY2013 · HL
Hematopoietic Cell Therapy for Young Adults with Severe Sickle Cell Disease$207,332
R34 · FY2012 · HL
Hematopoietic Cell Therapy for Young Adults with Severe Sickle Cell Disease$295,408
R34 · FY2011 · HL
Northern California Consortium for Sickle Cell Disease$286,461
U10 · FY2008 · HL · contact PI
Northern California Consortium for Sickle Cell Disease$134,901
U10 · FY2007 · HL · contact PI
Northern California Consortium for Sickle Cell Disease$138,930
U10 · FY2006 · HL · contact PI
Induction of Stable Chimerism for Sickle Cell Anemia$550,666
U01 · FY2004 · HL
Induction of Stable Chimerism for Sickle Cell Anemia$526,886
U01 · FY2003 · HL
Induction of Stable Chimerism for Sickle Cell Anemia$520,882
U01 · FY2002 · HL
Induction of Stable Chimerism for Sickle Cell Anemia$4,166
U01 · FY2002 · HL
Induction of Stable Chimerism for Sickle Cell Anemia$489,103
U01 · FY2001 · HL